{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:10:43Z","timestamp":1777018243522,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in <jats:italic>KAT6A<\/jats:italic>, encoding a member of the MYST family of histone acetyl-transferases, were recently reported in patients with a neurodevelopmental disorder (OMIM: #616268, autosomal dominant mental retardation-32). In this report, we describe three siblings with intellectual disability (ID) or global developmental delay and a <jats:italic>KAT6A<\/jats:italic> heterozygous nonsense mutation, i.e., c.3070C&gt;T (p.R1024*, ENST00000406337; chr8:41795056G&gt;A on hg19). This mutation was identified by whole-exome sequencing of all three siblings but not in a healthy sibling. The mutation was not detected in the peripheral blood of their parents, suggesting the existence of parental germline mosaicism. The primary symptoms of our patients included severe to profound ID or global developmental delay, including speech delay with craniofacial dysmorphism; these symptoms are consistent with symptoms previously described for patients with <jats:italic>KAT6A<\/jats:italic> mutations. Although several features are common among patients with <jats:italic>KAT6A<\/jats:italic> mutations, the features are relatively nonspecific, making it difficult to establish a clinical entity based on clinical findings alone. To the best of our knowledge, this is the first report of cases with a <jats:italic>KAT6A<\/jats:italic> mutation in an Asian population and these cases represent the first reported instances of germline mosaicism of this disease.<\/jats:p>","DOI":"10.1038\/hgv.2017.45","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T11:25:38Z","timestamp":1510226738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Three brothers with a nonsense mutation in KAT6A caused by parental germline mosaicism"],"prefix":"10.1038","volume":"4","author":[{"given":"Chisei","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-2509","authenticated-orcid":false,"given":"Hiroyuki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichiro","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"BFhgv201745_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ridd.2010.12.018","volume":"32","author":"PK Maulik","year":"2011","unstructured":"Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S . Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011; 32: 419\u2013436.","journal-title":"Res Dev Disabil"},{"key":"BFhgv201745_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11689-010-9055-2","volume":"2","author":"L Kaufman","year":"2010","unstructured":"Kaufman L, Ayub M, Vincent JB . The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord 2010; 2: 182\u2013209.","journal-title":"J Neurodev Disord"},{"key":"BFhgv201745_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature21062","volume":"542","author":"Deciphering Developmental Disorders Study","year":"2017","unstructured":"Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017; 542: 433\u2013438.","journal-title":"Nature"},{"key":"BFhgv201745_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","volume":"312","author":"Y Yang","year":"2014","unstructured":"Yang Y, Muzny DM, Xia F, Niu Z, Person R, Veeraraghavan N et al. molecular findings among patients referred for clinical whole- exome sequencing yaping. JAMA 2014; 312: 1870\u20131879.","journal-title":"JAMA"},{"key":"BFhgv201745_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/gim.2016.95","volume":"19","author":"KD Farwell Hagman","year":"2017","unstructured":"Farwell Hagman KD, Shinde DN, Mroske C, Smith E, Radtke K, Shahmirzadi L et al. Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. Genet Med 2017; 19: 224\u2013235.","journal-title":"Genet Med"},{"key":"BFhgv201745_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajhg.2015.01.016","volume":"96","author":"E Tham","year":"2015","unstructured":"Tham E, Lindstrand A, Santani A, Malmgren H, Nesbitt A, Dubbs HA et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. Am J Hum Genet 2015; 96: 507\u2013513.","journal-title":"Am J Hum Genet"},{"key":"BFhgv201745_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ajhg.2015.01.017","volume":"96","author":"VA Arboleda","year":"2015","unstructured":"Arboleda VA, Lee H, Dorrani N, Zadeh N, Willis M, Macmurdo CF et al. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet 2015; 96: 498\u2013506.","journal-title":"Am J Hum Genet"},{"key":"BFhgv201745_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/ajmg.a.37670","volume":"170","author":"F Millan","year":"2016","unstructured":"Millan F, Cho MT, Retterer K, Monaghan KG, Bai R, Vitazka P et al. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder. Am J Med Genet A 2016; 170: 1791\u20131798.","journal-title":"Am J Med Genet A"},{"key":"BFhgv201745_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491\u2013498.","journal-title":"Nat Genet"},{"key":"BFhgv201745_CR10","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.","journal-title":"Nucleic Acids Res"},{"key":"BFhgv201745_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00438-015-1130-7","volume":"291","author":"M Gajecka","year":"2015","unstructured":"Gajecka M . Unrevealed mosaicism in the next-generation sequencing era. Mol Genet Genomics 2015; 291: 513\u2013530.","journal-title":"Mol Genet Genomics"},{"key":"BFhgv201745_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/jhg.2016.27","volume":"61","author":"M Nakashima","year":"2016","unstructured":"Nakashima M, Takano K, Tsuyusaki Y, Yoshitomi S, Shimono M, Aoki Y et al. WDR45 mutations in three male patients with West syndrome. J Hum Genet 2016; 61: 653\u2013661.","journal-title":"J Hum Genet"},{"key":"BFhgv201745_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2015.05.008","volume":"97","author":"R Acuna-Hidalgo","year":"2015","unstructured":"Acuna-Hidalgo R, Bo T, Kwint MP, Van De Vorst M, Pinelli M, Veltman JA et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am J Hum Genet 2015; 97: 67\u201374.","journal-title":"Am J Hum Genet"},{"key":"BFhgv201745_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ng0996-33","volume":"14","author":"J Borrow","year":"1996","unstructured":"Borrow J, Stanton VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14: 33\u201341.","journal-title":"Nat Genet"},{"key":"BFhgv201745_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/sj.onc.1204114","volume":"20","author":"N Champagne","year":"2001","unstructured":"Champagne N, Pelletier N, Yang XJ . The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 2001; 20: 404\u2013409.","journal-title":"Oncogene"},{"key":"BFhgv201745_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.devcel.2009.10.006","volume":"17","author":"AK Voss","year":"2009","unstructured":"Voss AK, Collin C, Dixon MP, Thomas T . Moz and retinoic acid coordinately regulate H3K9 acetylation, hox gene expression, and segment identity. Dev Cell 2009; 17: 674\u2013686.","journal-title":"Dev Cell"},{"key":"BFhgv201745_CR17","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1242\/dev.01134","volume":"131","author":"CT Miller","year":"2004","unstructured":"Miller CT, Maves L, Kimmel CB . moz regulates Hox expression and pharyngeal segmental identity in zebrafish. Development 2004; 131: 2443\u20132461.","journal-title":"Development"},{"key":"BFhgv201745_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.chembiol.2014.02.013","volume":"21","author":"Y Kong","year":"2014","unstructured":"Kong Y, Grimaldi M, Curtin E, Dougherty M, Kaufman C, White RM et al. Neural crest development and craniofacial morphogenesis is coordinated by nitric oxide and histone acetylation. Chem Biol 2014; 21: 488\u2013501.","journal-title":"Chem Biol"},{"key":"BFhgv201745_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1101\/gad.1393106","volume":"20","author":"T Katsumoto","year":"2006","unstructured":"Katsumoto T, Aikawa Y, Iwama A, Ueda S, Ichikawa H, Ochiya T et al. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev 2006; 20: 1321\u20131330.","journal-title":"Genes Dev"},{"key":"BFhgv201745_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.devcel.2012.07.010","volume":"23","author":"AK Voss","year":"2012","unstructured":"Voss AK, Vanyai HK, Collin C, Dixon MP, McLennan TJ, Sheikh BN et al. MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. Dev Cell 2012; 23: 652\u2013663.","journal-title":"Dev Cell"}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/hgv201745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hgv201745","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hgv201745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/hgv201745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T19:10:36Z","timestamp":1671736236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hgv201745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,14]]}},"alternative-id":["BFhgv201745"],"URL":"https:\/\/doi.org\/10.1038\/hgv.2017.45","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"assertion":[{"value":"26 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17045"}}